Home / VERTEX PHARMACEUTICALS INC / MA (VRTX)

VERTEX PHARMACEUTICALS INC / MA (VRTX) Technical Analysis

Updated: 2026-06-16 09:26 UTC · Last close: 450.46 (+1.24%) · Support: 445.10 · Resistance: 499.17
VERTEX PHARMACEUTICALS INC / MA (VRTX) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.
⬇️ Support
445.10
⬆️ Resistance
499.17
⚠️ Risk Line
losing 444.93 would weaken the current structure.
🔺 Technical Setup
Breakout Watch
Downtrend line not broken yet · score 0
RSI(14)
57.1
🎯 Decision Map
The nearest decision zone is framed by support around 444.93 and resistance near 453.08. Clearing resistance would strengthen the constructive case, while a failure through support would damage the present setup. Pattern-based invalidation is near 523.16; losing that area would weaken the active formation considerably.
📊 Technical Summary
At a glance
Trend
Constructive
Momentum
Neutral
Range
63% of 52W range
Key Zone
445.10 / 499.17
The latest close for VERTEX PHARMACEUTICALS INC / MA (VRTX) came in at 450.46 (+1.24%). Trend remains constructive above MA50 and MA200. Momentum stays positive (+3.09%), with 52W position: 63% of range, while Volatility: ATR14 2.58%. RSI(14) is 57.1, leaving momentum in a fairly neutral range. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD remains above its signal line, which keeps the momentum structure biased to the upside. The MACD histogram is positive and expanding, pointing to improving upside momentum.
🔺
Setup: From a pattern perspective, the main active signal is Double top.
🎯
Key levels: Near-term structure is defined by support at 445.10 and resistance at 499.17.
🚀
Trigger: A clean break above resistance would strengthen the chart, while a loss of support would put the current setup under pressure.
💼 Fundamentals Snapshot
Source: sec
💼 Business Lens
QUALITY VIEW
Financial quality snapshot
Long-term structure remains supportive
📈 Growth: Improving 💰 Profit: Positive 💵 Cash: Pressured 🛡 Balance: Manageable
• Quarterly revenue is improving again after a softer stretch.
• Quarterly profitability is positive, though margins are not especially strong.
💵 Revenue
2.99B
📈 Net Income
1.03B
🧮 EPS (Basic)
4.06
🏢 Company
VERTEX PHARMACEUTICALS INC / MA
🏷 Sector
Healthcare
🧩 Industry
Biotech
Compare with related stocks
Same sector and industry ideas for deeper research
Amgen (AMGN) technical analysisAxsome Therapeutics (AXSM) technical analysisBeam Therapeutics (BEAM) technical analysisCRISPR Therapeutics AG (CRSP) technical analysisAmicus Therapeutics (FOLD) technical analysisImmunitybio (IBRX) technical analysisAbbVie (ABBV) technical analysis
WOI OPEN ADVANCED ANALYSIS WORKSPACE
Note: This is an algorithmic technical snapshot (not financial advice).
VRTX Chart